Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sofosbuvir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05
- Strength
- 400 mg
- Dosage form
- Tablet
- Pack
- 14's
- Registration no.
- 080176
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-10 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Sofos (Sofosbuvir) is used for
Sofosbuvir is an antiviral medicine for hepatitis C. It blocks a protein that the hepatitis C virus needs to make copies of itself, so the amount of virus in the body goes down and, over time, the virus is cleared from the blood. It belongs to a group of hepatitis C medicines called direct-acting antivirals. Sofosbuvir does not work on its own: it is always taken together with at least one other hepatitis C medicine. Treatment is planned and checked by a specialist, using blood tests before, during and after the course. Young children may be given it as small pellets instead of tablets.
- Long-term (chronic) hepatitis C infection in adults and children aged 3 and over
- Always in combination with other hepatitis C medicines, such as daclatasvir, velpatasvir, ledipasvir or ribavirin
- In the UK leaflet, it is combined with ribavirin, or in adults with peginterferon alfa and ribavirin
Get medical help straight away if
- If you take, or have taken in the last few months, the heart medicine amiodarone, get urgent help for a slow or irregular heartbeat, a pounding heart, chest pain, breathlessness, feeling light-headed, or fainting or nearly fainting. The two medicines together can slow the heart dangerously.
- Get urgent medical help for a severe, widespread rash with peeling skin or blisters, especially with fever, flu-like feelings or sores in the mouth, eyes or genitals (Stevens-Johnson syndrome).
- Call your doctor straight away for signs that hepatitis B may be flaring up: unusual tiredness, yellow skin or eyes, loss of appetite, feeling or being sick, pale stools, stomach pain or dark urine. This can happen during or after treatment in people who have ever had hepatitis B.
- Call your doctor straight away for pale skin, dizziness, shortness of breath, weakness, chest pain, confusion or memory problems.
Side effects, warnings and interactions for Sofosbuvir
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Sofosbuvir
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Sofosbuvir is right for you and the dose.
- Hepatitis C: first-choice low-cost pangenotypic treatment, the most widely used combination in many low- and middle-income countries
About Sofos 400 mg tablet
Sofos 400 mg tablet contains Sofosbuvir 400 mg. It is registered with DRAP by M/s. Genix Pharma (Pvt) Ltd (registration no. 080176). Its official price is PKR 6,059.48 for a pack of 14's, about PKR 432.82 per tablet. This price has applied since 23 July 2026. It is sold in 2 pack sizes: 14's and 28's. 53 other brands of Sofosbuvir 400 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Sofos 400 mg pack sizes and prices
| Pack | Official price | Per tablet |
|---|---|---|
| 14's (this page) | PKR 6,059.48 | PKR 432.82 |
| 28's | PKR 12,118.98 | PKR 432.82 |
All 53 other brands of Sofosbuvir 400 mg tablet in Pakistan
These 53 brands are alternatives (substitutes) to Sofos: each contains Sofosbuvir 400 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is NUCLEOBUVIR (AA Pharma) at PKR 264 per tablet; the highest is Lesof Plus at PKR 2,039. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| NUCLEOBUVIR | AA Pharma | 28's | PKR 7,382.54 | PKR 264 / tablet |
| Sofozaf | Zafa Pharmaceutical Laboratories (Pvt) Ltd | 28's | PKR 8,154.99 | PKR 291 / tablet |
| Cure-C | Global Pharmaceuticals (Pvt.) Ltd | 28's | PKR 9,352.82 | PKR 334 / tablet |
| Solbovir | Nabiqasim Industries (Pvt) Ltd | 28’s | PKR 10,126.88 | PKR 362 / tablet |
| ZIQAR | Wilshire Laboratories (Private) Limited | 28's | PKR 10,297.81 | PKR 368 / tablet |
| Cell | Werrick Pharmaceuticals | 28's | PKR 10,835.76 | PKR 387 / tablet |
| Saferon | Wilson's Pharmaceuticals | 28's | PKR 10,835.76 | PKR 387 / tablet |
| Virohep | Dyson Research Laboratories (Pvt.) Ltd | 28's | PKR 11,018.43 | PKR 394 / tablet |
| Lavie | The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd | 28's | PKR 11,038.19 | PKR 394 / tablet |
| SOVIR | Lucky Core Industries Limited | 28'S | PKR 11,364.67 | PKR 406 / tablet |
| CHC-400 | Genome Pharmaceuticals (Pvt.) Ltd | 4 x 7's | PKR 11,391.64 | PKR 407 / tablet |
| Lesof | Bio-Labs(Pvt) Ltd | 28's | PKR 11,391.65 | PKR 407 / tablet |
| Hepgard | Barrett Hodgson Pakistan (Pvt.) Ltd | 28's | PKR 11,392.51 | PKR 407 / tablet |
| Hepaldi | Scotmann Pharmaceuticals | 4x7's | PKR 11,392.70 | PKR 407 / tablet |
| Qvir | Bosch Pharmaceuticals (Pvt) Ltd | 28's | PKR 11,392.72 | PKR 407 / tablet |
| Sofotel | Helix Pharma (Pvt)., Ltd | 28's | PKR 11,392.72 | PKR 407 / tablet |
| Safaldi | Saffron Pharmaceuticals | 28’s | PKR 11,392.72 | PKR 407 / tablet |
| Sofhep | Aspin Pharma | 28's | PKR 11,704.67 | PKR 418 / tablet |
| Savera | Ferozsons Laboratories Limited | 28's | PKR 11,704.67 | PKR 418 / tablet |
| Vebuvir | Shaigan Pharmaceuticals (Pvt) Ltd | 28's | PKR 11,704.88 | PKR 418 / tablet |
Show all 53 brands
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Neosofo | Neutro Pharma (Pvt.) Ltd | 28's | PKR 11,704.88 | PKR 418 / tablet |
| Hep-C-Vir | CRYSTOLITE PHARMACEUTICALS | 28’s | PKR 11,704.88 | PKR 418 / tablet |
| Fosbu | Highnoon Laboratories Ltd | 28 | PKR 11,705.11 | PKR 418 / tablet |
| Basovir | HIGH-Q Pharmaceuticals | 28's | PKR 11,708.49 | PKR 418 / tablet |
| Sofonil | NovaMed Pharmaceuticals(Pvt.)Ltd | 28's | PKR 11,946.02 | PKR 427 / tablet |
| Novus | S.J & G. Fazul Ellahie (pvt) limited | 28's | PKR 11,947.21 | PKR 427 / tablet |
| C-OFF | Atco Laboratories Limited | 28's | PKR 11,948.35 | PKR 427 / tablet |
| Scihop | Scilife Pharma Private Limited | 28's | PKR 11,948.58 | PKR 427 / tablet |
| Sobvi | The Searle Company Limited | 28's | PKR 11,948.58 | PKR 427 / tablet |
| OZBIR | Martin Dow Limited | 28's | PKR 11,948.58 | PKR 427 / tablet |
| VIBRENTA | TABROS PHARMA (PVT). LTD | 28'S | PKR 12,118.01 | PKR 433 / tablet |
| MYHEP | AGP Limited | 28's | PKR 12,118.05 | PKR 433 / tablet |
| SOFOHIL | Hilton Pharma (Pvt) Limited | 28's | PKR 12,118.06 | PKR 433 / tablet |
| Fosvirol | Pharmasol (Pvt) Ltd | 28's | PKR 12,119.19 | PKR 433 / tablet |
| ABRIVA | CCL Pharmaceuticals (Pvt.) Limited | 28's | PKR 12,119.20 | PKR 433 / tablet |
| Sofomac | Macter International Limited | 28's | PKR 12,119.21 | PKR 433 / tablet |
| OCVIR | SAMI Pharmaceuticals Pvt. Ltd | 28's | PKR 12,119.44 | PKR 433 / tablet |
| Sofiget | Getz Pharma (Pvt) Limited | 28's | PKR 12,119.45 | PKR 433 / tablet |
| Zoval | PHARMEVO (PVT) LTD | 4 x 7's | PKR 12,119.45 | PKR 433 / tablet |
| Safaldi-V | Saffron Pharmaceuticals | 28's | PKR 16,057.26 | PKR 573 / tablet |
| Lecur | The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd | 28's | PKR 16,507.47 | PKR 590 / tablet |
| Vebvel | Shaigan Pharmaceuticals (Pvt) Ltd | 28's | PKR 18,465.85 | PKR 659 / tablet |
| CHC Plus-400mg | Genome Pharmaceuticals (Pvt.) Ltd | 28's | PKR 19,413.15 | PKR 693 / tablet |
| HILVEL 400mg | Hilton Pharma (Pvt) Limited | 7's | PKR 4,926.88 | PKR 704 / tablet |
| Sepavir | CRYSTOLITE PHARMACEUTICALS | 28’s | PKR 19,946.96 | PKR 712 / tablet |
| Sofvel 400mg | Aspin Pharma | 28's | PKR 20,598.24 | PKR 736 / tablet |
| MYHEP ALL | AGP Limited | 28's | PKR 20,598.25 | PKR 736 / tablet |
| Sowaita | Scilife Pharma Private Limited | 28's | PKR 21,708.00 | PKR 775 / tablet |
| Rivofos | Genetics Pharmaceuticals Pvt. Ltd | 10's | PKR 12,112.78 | PKR 1,211 / tablet |
| Twinvir | Scilife Pharma Private Limited | 28's | PKR 49,633.92 | PKR 1,773 / tablet |
| Safaldi-L | Saffron Pharmaceuticals | 28's | PKR 49,634.86 | PKR 1,773 / tablet |
| Vebuvir-L 400mg | Shaigan Pharmaceuticals (Pvt) Ltd | 28's | PKR 54,289.61 | PKR 1,939 / tablet |
| Lesof Plus | Bio-Labs(Pvt) Ltd | 28's | PKR 57,079.82 | PKR 2,039 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Sofos, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- M/s. Genix Pharma (Pvt) Ltd., Karachi
- DRAP registration
- 080176
- Phone
- +92 21 111 10 10 11
- info@genixpharma.com
- Website
- https://www.genixpharma.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (14's). Current price PKR 6,059.48, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Sofos 400 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/sofos-400-mg-080176-14s-m-s-genix-pharma-pvt-ltd-7545/ (accessed 10 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 6,059.48 | 2026-07-23 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 080176Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
